Dolutegravir Sodium acts as an antiviral treatment for managing viral infections. Inhibiting specific protein actions stops viral spread, assisting your immune system to function more consistently over time.
When the immune system is weakened by HIV, controlling the virus becomes essential. Dolutegravir sodium belongs to a class of medicines called integrase inhibitors, which help prevent the virus from making new copies of itself. This action assists with keeping the viral load low and supporting overall immune health. It is the active compound in several HIV therapies such as Tivicay, Dolutegravir and Triumeq that are available in Singapore.
You’ll see dolutegravir sodium in both brand-name and generic HIV medicines marketed locally. Common forms include oral tablets for daily use, and combination pills that pair dolutegravir with other antiretrovirals, like the three-drug tablet Triumeq. In Singapore, clinicians may prescribe the branded version Tivicay or the generic dolutegravir tablet, depending on availability and patient needs. All of these products share the same active ingredient while differing in strength and accompanying drugs.
People living with HIV often need lifelong therapy to keep the virus suppressed. Dolutegravir sodium-based medicines are used to treat HIV-1 infection in adults and adolescents. They are also part of treatment plans for patients who have previously taken other antiretroviral regimens and need a switch to a simpler, once-daily option. The medication may be recommended for individuals with high viral loads who require a potent integrase inhibitor to assist with viral control.
Dolutegravir sodium blocks an enzyme called integrase, which the HIV virus uses to insert its genetic material into human cells. By stopping this step, the drug reduces the number of new infected cells and helps keep the amount of virus in the blood low. This simple mechanism allows the immune system to recover and operate more effectively over time.
Mild nausea, headache, and occasional fatigue are among the most frequently reported experiences. Some people notice a brief increase in appetite or mild stomach discomfort after the first few doses. These symptoms usually resolve without medical intervention.
Rare but important warning signs include severe rash, signs of liver trouble such as yellowing of the skin or eyes, and unexplained fever. If any of these occur, urgent medical attention is recommended.
Dolutegravir sodium should be used with caution in pregnant individuals, as safety data are still being gathered. People with known hypersensitivity to the ingredient or any of its inactive components should avoid it. Those with significant kidney impairment may also require special consideration.
Alcohol does not directly interfere with the drug, but excessive drinking can affect overall treatment adherence. Certain medicines, such as some anticonvulsants and tuberculosis drugs, can lower dolutegravir levels; checking the package insert or pharmacy label for exact interaction details is essential.
Storing tablets in a dry place at room temperature helps maintain their stability. Most dolutegravir-containing products are taken once daily, but the exact duration of therapy depends on the individual’s treatment plan and the specific medication chosen. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of dolutegravir sodium and is not medical advice. Medicines containing this ingredient-such as Tivicay, Dolutegravir and Triumeq-may differ in formulation, strength, and directions. The information shared here does not replace professional clinical judgment, and liability for any clinical application is expressly disclaimed. Readers should review the labeling of their specific medication and seek guidance from a healthcare professional.
For more details, you may consult the following resources.
